Search Bar & Filters
Found 9 Actively Recruiting clinical trials
Actively Recruiting
Researchers are studying the safety and effectiveness of pirtobrutinib LOXO-305 compared to ibrutinib in adults with chronic lymphocytic leukemia CLL or small lymphocytic lymphoma SLL. The study includes participants who may or may not have received prior treatment for their cancer and focuses on those with specific genetic markers, like 17p deletions, in one part of the trial. This is a phase 3, open-label study sponsored by Loxo Oncology, Inc. Participants receive either pirtobrutinib or ibrutinib as oral treatments. The study has two parts Part 1 compares pirtobrutinib and ibrutinib in a broad group of participants and may last up to six years, while Part 2 evaluates pirtobrutinib alone in treatment-nafve participants with 17p deletions for up to two years. Treatments are taken by mouth, and participants are randomly assigned to treatment groups. During the study, participants will undergo regular assessments to monitor their response to treatment, including checking for complete or partial remission. Researchers will evaluate progression-free survival, overall survival, duration of response, and tolerability over several years. Safety and effectiveness are closely tracked with scheduled visits and tests until data cutoff or disease progression. Participation can last up to six years depending on the study part.
Actively Recruiting
Healthy Volunteer
Hip and knee replacement surgeries are common among older adults, but many patients face pain, limited movement, and sleep difficulties during recovery. These problems can make daily tasks like walking or climbing stairs harder and reduce overall quality of life. Researchers are evaluating two different relaxation methods to see how they affect pain and sleep quality after such surgeries. The study compares relaxation exercises delivered through virtual reality technology with traditional relaxation exercises without virtual reality. Both approaches are provided alongside standard postoperative care. Patients are randomly assigned to one of these two groups, and the study is double-blinded to reduce bias. Participants will engage in the assigned relaxation exercises after surgery, and researchers will assess pain intensity and sleep quality over the first three days following the operation. The study will include evaluations of pain levels using standard scales and measures of sleep quality to understand how each relaxation method may support recovery. The total participation duration is centered around the postoperative period of three days.
Actively Recruiting
Healthy Volunteer
Researchers are studying the effects of a Hope-Focused Motivational Interviewing program on patients with cancer who are receiving radiotherapy. This randomized controlled trial aims to evaluate changes in hope, self-efficacy, and self-compassion levels among these patients using a pretest-posttest and follow-up design. The study involves adult cancer patients undergoing inpatient care in a Radiation Oncology unit and is sponsored by Saglik Bilimleri Universitesi. Participants are randomly assigned to either an intervention group or a control group. The intervention group receives four individual sessions of Hope-Focused Motivational Interviewing twice weekly, each lasting about 30-40 minutes. These sessions focus on exploring hope and goal setting, enhancing self-efficacy, developing self-compassion, and coping with barriers to create sustainable coping plans. The control group receives routine care without any structured psychosocial intervention during the study period. Data collection occurs at baseline, immediately after the 2-week intervention, and 1 month later. Participants complete questionnaires including the Herth Hope Index, Brief Self-Compassion Scale, and General Self-Efficacy Scale through Google Forms, with each session lasting approximately 15-20 minutes. Informed consent is obtained before participation. Researchers measure outcomes at three time points to assess changes in hope, self-compassion, and self-efficacy. The study spans from baseline through post-intervention and a 1-month follow-up, focusing on supportive care in cancer treatment.
Actively Recruiting
Researchers are evaluating the efficacy and safety of adagrasib MRTX849 alone and combined with pembrolizumab in patients with advanced or metastatic non-small cell lung cancer NSCLC who have a KRAS G12C mutation. The study includes both Phase 2 and Phase 3 portions, focusing on patients eligible for first-line treatment with varying levels of PD-L1 expression. The trial compares adagrasib combined with pembrolizumab to pembrolizumab alone in patients with high PD-L1 expression. In Phase 2, patients are divided into three groups based on PD-L1 TPS scores two groups with scores below 1% receive either adagrasib monotherapy or adagrasib plus pembrolizumab, and one group with scores of 1% or higher receives the combination. Phase 3 randomizes patients with PD-L1 TPS of 50% or higher to receive either adagrasib plus pembrolizumab or pembrolizumab alone. Adagrasib is taken orally twice daily, while pembrolizumab is given intravenously every three weeks. Participants undergo regular assessments including brain imaging, tumor measurements, and quality of life questionnaires. Researchers monitor treatment effects, safety, drug levels in blood, and lung cancer symptoms over periods of up to 22 months in Phase 2 and 36 months in Phase 3. The study also evaluates progression-free survival, response duration, and other outcomes to understand the treatments impact.
Actively Recruiting
Healthy Volunteer
Researchers are evaluating the effects of a prenatal yoga program on how pregnant women perceive traumatic childbirth, their self-image, and their preferences for delivery. This study involves voluntary pregnant women aged 18 years and older who are at or beyond 16 weeks of pregnancy and do not have a high-risk pregnancy. Participants are randomly assigned to either receive prenatal yoga sessions or continue with routine prenatal care. The intervention group participates in a structured prenatal yoga program consisting of eight sessions delivered twice a week, each lasting about 45 minutes and following safe prenatal exercise guidelines. The control group continues with standard prenatal care without additional interventions. The yoga program is conducted in small groups of 8 to 12 participants and takes place over approximately four weeks. Participants complete assessments at the start of the study, immediately after finishing the eight yoga sessions, and again one month later. These assessments include questionnaires measuring traumatic childbirth perception, self-perception, and delivery preferences. The study monitors outcomes related to childbirth experience and personal perceptions, with data collected through well-established scales at three different time points during the study period.
Actively Recruiting
Researchers are evaluating pumitamig BNT327 combined with chemotherapy etoposidecarboplatin compared to atezolizumab combined with the same chemotherapy for participants with previously untreated extensive-stage small-cell lung cancer. This Phase III, multisite, randomized, double-blinded study aims to compare these treatments to better understand options for first-line ES-SCLC therapy. The study has two stages involving different treatment arms. Stage 1 includes two pumitamig doses combined with chemotherapy and one control arm with atezolizumab plus chemotherapy. Stage 2 has one pumitamig dose treatment arm and a control arm with atezolizumab plus chemotherapy. Participants receive intravenous infusions of study drugs, with the option to switch from carboplatin to cisplatin if needed. Each stage has a screening period up to 21 days, followed by induction and maintenance treatment until disease progression, intolerable side effects, withdrawal, study end, or up to 2 years, then a safety and survival follow-up period. Participants undergo screening to confirm eligibility, then receive treatments according to randomization. Assessments include survival, progression-free survival, response rates, duration of response, and quality of life measured through questionnaires. Safety monitoring tracks adverse events and treatment delays or discontinuations. Follow-up includes safety visits and survival tracking, with total participation lasting up to approximately 46 months from start. The study is designed to monitor long-term outcomes and tolerability of these combinations in ES-SCLC treatment.
Actively Recruiting
Researchers are studying how watching an educational video about ear tube surgery affects anxiety and fear in children aged 6 to 10 years undergoing this procedure. This randomized controlled trial compares children who view a specially designed video explaining the surgery, its steps, and what to expect, with children receiving the standard information currently given in the hospital. The goal is to see if the video can reduce preoperative anxiety and fear in these pediatric surgical patients. Children will be randomly assigned to one of two groups the educational animation group or the control group receiving standard care information. The educational video, lasting 3 to 4 minutes, is narrated by artificial intelligence and covers common fears, ear anatomy, details about the ear tube, and the surgical process. The control group will receive the usual information provided in the hospital ward. This study is conducted over a 12-month period starting from November 2024. Participants will be assessed using questionnaires before and after surgery to measure anxiety and fear levels, including the Child Anxiety Scale and Child Fear Scale. Data will be collected on childrens emotional responses and changes in anxiety and fear after the video intervention. The study also tracks sociodemographic information. Safety and adherence will be monitored throughout the trial, which ends in December 2025.
Actively Recruiting
Healthy Volunteer
Researchers are evaluating the effects of using surgical masks compared to N95 masks on physical symptoms caused by surgical smoke in operating room nurses. The study focuses on understanding how different types of masks impact symptoms such as muscle weakness, respiratory issues, and eye irritation related to exposure to surgical smoke during surgeries. This interventional study involves nurses working in a hospital operating theatre setting. The study includes two groups where operating room nurses wear either a standard surgical mask or an N95 respirator during surgical procedures with exposure to surgical smoke. The nurses use each type of mask continuously for at least four hours per day over a four-week period. Physical symptoms are monitored and compared between the two mask types to assess their effect on symptom severity. Participants are asked to use the assigned mask type during surgeries and report their symptoms daily using rating scales and symptom tracking forms. Data collection occurs five days a week for four weeks both before and after surgery. Researchers measure physical symptoms such as muscle weakness, myalgia, muscle cramps, respiratory parameters, watery eyes, and redness. The study monitors symptom severity using a numerical rating scale and evaluates the differences between mask types to understand the impact on surgical smoke-related symptoms.
Actively Recruiting
Healthy Volunteer
Researchers are evaluating the effects of a trauma-informed yoga program on psychological trauma symptoms, emotional regulation difficulties, and interoceptive awareness in young adult women aged 18 to 25. The study aims to better understand how this specialized yoga intervention might influence these important psychological and emotional aspects. Participants will be randomly assigned to either an intervention group or a control group. Those in the intervention group will take part in eight group-based yoga sessions, each lasting about 45 minutes, held twice a week. The yoga program follows trauma-informed principles and covers themes such as safety, body awareness, emotion integration, forgiveness, empowerment, self-compassion, and future orientation. The control group will not receive this intervention but will continue their usual routines. During the study, participants will complete assessments before the program, immediately after, and one month later. These include measures of psychological trauma symptoms, emotional regulation, and interoceptive awareness. The study involves monitoring participants adherence to sessions and collecting data to evaluate changes over time. The total study duration spans from June to November 2026, with primary outcomes assessed up to one month post-intervention.